Evaluation of Hepatitis C Viral Load Quantification on DBS in Vietnam (MOVIDA-Hep)
Primary Purpose
Hepatitis C, Dried Blood Spot
Status
Completed
Phase
Not Applicable
Locations
Vietnam
Study Type
Interventional
Intervention
Blood sampling
Sponsored by

About this trial
This is an interventional diagnostic trial for Hepatitis C focused on measuring HCV Viral Load, Dried Blood Spot, HCV Core Ag
Eligibility Criteria
Inclusion Criteria:
- ≥18 years of age
- Known HCV infection
- Willing to participate to the study by giving his/her consent.
Exclusion Criteria:
None
Sites / Locations
- Dong Da Hospital
- Nam Tu Liem Hospital
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
Blood sampling
Arm Description
blood samples from venepuncture (10mL) and from fingertip (approximatively 0.4mL) on a dried blood spots
Outcomes
Primary Outcome Measures
Quantification of HCV RNA on DBS compared to plasma as gold standard
Sensitivity and specificity of HCV RNA VL measured on DBS collected by venipuncture
Secondary Outcome Measures
Quantification of HCV RNA measured on DBS using plasma as gold standard
Sensitivity and specificity of HCV RNA VL measured on DBS collected by finger prick
Correlation between HCV RNA VL measured on DBS and on plasma.
Correlation between HCV RNA VL measured on DBS (collected by venipuncture and finger prick) and on plasma.
Quantification of HCV core antigen using HCV RNA VL as gold standard
Sensitivity and specificity of HCV core antigen using HCV RNA VL as gold standard
Correlation between HCV core antigen and HCV RNA VL on plasma
Correlation between HCV core antigen and HCV RNA VL, both measured on plasma.
Quantification of HCV core antigen measured on DBS using HCV RNA VL measured on plasma as gold standard.
Sensitivity and specificity of HCV core antigen measured on DBS collected by venipuncture using HCV RNA VL measured on plasma as gold standard.
Correlation between HCV core antigen measured on DBS and HCV RNA VL measured on plasma.
Correlation between HCV core antigen measured on DBS collected by venipuncture and HCV RNA VL measured on plasma.
Full Information
NCT ID
NCT03670251
First Posted
September 10, 2018
Last Updated
March 21, 2022
Sponsor
Institut Pasteur
Collaborators
National Institute of Hygiene and Epidemiology - Vietnam (NIHE), Hanoi University of Public Health
1. Study Identification
Unique Protocol Identification Number
NCT03670251
Brief Title
Evaluation of Hepatitis C Viral Load Quantification on DBS in Vietnam
Acronym
MOVIDA-Hep
Official Title
Improving Access to Viral Load Monitoring in HIV-infected Patients on ART in Decentralised Area Using Dried Blood Spot : Evaluation of Hepatitis C Viral Load Quantification on DBS
Study Type
Interventional
2. Study Status
Record Verification Date
February 2020
Overall Recruitment Status
Completed
Study Start Date
May 9, 2019 (Actual)
Primary Completion Date
July 11, 2019 (Actual)
Study Completion Date
July 11, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Institut Pasteur
Collaborators
National Institute of Hygiene and Epidemiology - Vietnam (NIHE), Hanoi University of Public Health
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
In Vietnam, the prevalence of hepatitis C virus (HCV) infection is estimated between 0.4% and 5%, which is much higher than the prevalence in Europe or in the USA. After HCV diagnosis, HCV viral load quantification is crucial in order to distinguish recovered from active (on-going) HCV infection and hence identify those who need antiviral treatment to cure HCV infection. HCV viral load quantification is also important to assess treatment efficacy.
Currently, anti-HCV antibodies detection is available around the country. However, access to confirmation of HCV viremia remains scarce particularly in decentralized areas. One of the reason is the limited number of laboratories able to perform this complex biological measurement; moreover, these laboratories are situated only in large urban centres.
Blood sampling using DBS could help overcome this difficulty of access to a laboratory, and widen access to HCV viral load monitoring.
The present MOVIDA Hep study aims at validating the use of DBS to measure HCV viral load as compared to plasma (gold standard). A secondary objective is to evaluate the measurement of HCV core antigen on DBS. For this, 315 patients need to be enrolled form outpatient clinics in Hanoi. The laboratory in charge of these measurements would be the virology laboratory of the National Institute of Hygiene and Epidemiology (NIHE) in Hanoi (Vietnam).
Detailed Description
The "Monitoring Of Viral load In Decentralised Area" (MOVIDA) project aims at giving access to viral load (VL) monitoring to the patients coming from remote areas using Dried Blood Spot as tool of sampling.
In resource-limited settings, many biological exams are not accessible to the entire population due to logistic and financial constraints. Regarding infection with hepatitis B and C viruses (HBV and HCV), serological screening tests are easy to perform and are available nationwide in either laboratory format or rapid diagnosis tests. However, hepatitis B DNA and C RNA assessment is not available in decentralised area as no laboratory is able to perform this complex biological measurement.
WHO, in their latest guidelines, recommends using dried blood spots (DBS) as an alternative to serum or plasma. Blood is easy to collect on DBS, either after veni- or capillary puncture. Capillary blood collection can be of great interest when venipuncture is complex, for example in injecting drug users (IDUs) in whom finding an accessible vein can be difficult. Then it is easily transferred, and at a low cost as it does not require a cold chain, to a laboratory able to perform the HCV VL quantification. As of today, little is known about the performance of standard commercial HCV diagnostic assays when using DBS and none of these studies were performed in routine setting in resource-limited setting.
In Vietnam, HCV seroprevalence in the general population is estimated between 0.4% and 5%, which is much higher than the prevalence in Europe or in the US. Genotype 1 is the more prevalent in Vietnam, genotype 6 that is only found in South East Asia is the second most frequent, but other genotypes are circulating . In Vietnam, HCV prevalence is much higher in the HIV-infected population and in injecting drug users (IDUs). Currently, anti-HCV antibodies detection is available around the country even if some difficulties remain. However, access to HCV HCV viral load measurement in routine remains scarce particularly in decentralized areas because the technique is complex, expensive and need well-trained personnel and high standard of equipment. Thus, HCV viral load measurement remains non accessible to the vast majority of patients diagnosed with HCV.
This study (MOVIDA Hep) aims at evaluating the quality of HCV VL monitoring when using DBS (collection of venous and capillary blood) as compared to plasma (gold standard), in routine condition and using the existing machines. This, to find out if DBS can be used for HCV viremia confirmation in Vietnam, in the virology laboratory of the National Institute of Hygiene and Epidemiology (NIHE) in Hanoi (Vietnam) where these measurements would be performed.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hepatitis C, Dried Blood Spot
Keywords
HCV Viral Load, Dried Blood Spot, HCV Core Ag
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
315 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Blood sampling
Arm Type
Other
Arm Description
blood samples from venepuncture (10mL) and from fingertip (approximatively 0.4mL) on a dried blood spots
Intervention Type
Procedure
Intervention Name(s)
Blood sampling
Intervention Description
Blood sample of 10 mL by venipuncture and 0,4 mL by finger prick
Primary Outcome Measure Information:
Title
Quantification of HCV RNA on DBS compared to plasma as gold standard
Description
Sensitivity and specificity of HCV RNA VL measured on DBS collected by venipuncture
Time Frame
Up to 4 weeks
Secondary Outcome Measure Information:
Title
Quantification of HCV RNA measured on DBS using plasma as gold standard
Description
Sensitivity and specificity of HCV RNA VL measured on DBS collected by finger prick
Time Frame
Up to 4 weeks
Title
Correlation between HCV RNA VL measured on DBS and on plasma.
Description
Correlation between HCV RNA VL measured on DBS (collected by venipuncture and finger prick) and on plasma.
Time Frame
Up to 6 months
Title
Quantification of HCV core antigen using HCV RNA VL as gold standard
Description
Sensitivity and specificity of HCV core antigen using HCV RNA VL as gold standard
Time Frame
Up to 8 weeks
Title
Correlation between HCV core antigen and HCV RNA VL on plasma
Description
Correlation between HCV core antigen and HCV RNA VL, both measured on plasma.
Time Frame
Up to 6 months
Title
Quantification of HCV core antigen measured on DBS using HCV RNA VL measured on plasma as gold standard.
Description
Sensitivity and specificity of HCV core antigen measured on DBS collected by venipuncture using HCV RNA VL measured on plasma as gold standard.
Time Frame
Up to 8 weeks
Title
Correlation between HCV core antigen measured on DBS and HCV RNA VL measured on plasma.
Description
Correlation between HCV core antigen measured on DBS collected by venipuncture and HCV RNA VL measured on plasma.
Time Frame
Up to 6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
≥18 years of age
Known HCV infection
Willing to participate to the study by giving his/her consent.
Exclusion Criteria:
None
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Fabien TAIEB, MD, PhD, MPH
Organizational Affiliation
Institut Pasteur
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Tuan Anh NGUYEN, MD, PhD
Organizational Affiliation
National Institute of Hygiene and Epidemiology (NIHE)
Official's Role
Principal Investigator
Facility Information:
Facility Name
Dong Da Hospital
City
Hanoi
Country
Vietnam
Facility Name
Nam Tu Liem Hospital
City
Hanoi
Country
Vietnam
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
29425216
Citation
Taieb F, Tran Hong T, Ho HT, Nguyen Thanh B, Pham Phuong T, Viet Ta D, Le Thi Hong N, Ba Pham H, Nguyen LTH, Nguyen HT, Nguyen TT, Tuaillon E, Delaporte E, Le Thi H, Tran Thi Bich H, Nguyen TA, Madec Y. First field evaluation of the optimized CE marked Abbott protocol for HIV RNA testing on dried blood spot in a routine clinical setting in Vietnam. PLoS One. 2018 Feb 9;13(2):e0191920. doi: 10.1371/journal.pone.0191920. eCollection 2018.
Results Reference
background
PubMed Identifier
27704001
Citation
Taieb F, Tram TH, Ho HT, Pham VA, Nguyen L, Pham BH, Tong LA, Tuaillon E, Delaporte E, Nguyen AT, Bui DD, Do N, Madec Y. Evaluation of Two Techniques for Viral Load Monitoring Using Dried Blood Spot in Routine Practice in Vietnam (French National Agency for AIDS and Hepatitis Research 12338). Open Forum Infect Dis. 2016 Jul 7;3(3):ofw142. doi: 10.1093/ofid/ofw142. eCollection 2016 Sep.
Results Reference
background
PubMed Identifier
26333945
Citation
Soulier A, Poiteau L, Rosa I, Hezode C, Roudot-Thoraval F, Pawlotsky JM, Chevaliez S. Dried Blood Spots: A Tool to Ensure Broad Access to Hepatitis C Screening, Diagnosis, and Treatment Monitoring. J Infect Dis. 2016 Apr 1;213(7):1087-95. doi: 10.1093/infdis/jiv423. Epub 2015 Sep 2.
Results Reference
background
PubMed Identifier
31981287
Citation
Tran TH, Nguyen BT, Nguyen TA, Pham TTP, Nguyen TTT, Mai HTB, Pham HB, Nguyen TM, Phan HTT, Do NT, Ait-Ahmed M, Taieb F, Madec Y. Dried blood spots perform well to identify patients with active HCV infection in Vietnam. J Viral Hepat. 2020 May;27(5):514-519. doi: 10.1111/jvh.13263. Epub 2020 Feb 11.
Results Reference
result
Links:
URL
http://apps.who.int/iris/bitstream/10665/254621/1/9789241549981-eng.pdf
Description
WHO Guidelines on Hepatitis B and C Testing
Learn more about this trial
Evaluation of Hepatitis C Viral Load Quantification on DBS in Vietnam
We'll reach out to this number within 24 hrs